The Shifting Standard of “Safe”: What a Re-Evaluation of Food Additives Really Means
The question of what constitutes a “safe” food ingredient is rarely static, but a recent announcement from Health and Human Services Secretary Robert F. Kennedy Jr. signals a potentially seismic shift in how the Food and Drug Administration assesses the safety of commonly used processed carbohydrates. While headlines proclaim a coming crackdown on “ultraprocessed foods,” the core of the issue isn’t necessarily about banning ingredients, but about fundamentally altering how those ingredients are deemed safe for consumption. This isn’t a new concern – the debate over the FDA’s “Generally Recognized as Safe” (GRAS) designation has simmered for decades – but the current momentum, driven by Kennedy and former FDA Commissioner David Kessler, suggests a genuine possibility of change.
The GRAS designation, established by Congress in 1958, allows food companies to self-determine the safety of additives without direct FDA oversight, provided they have a reasonable basis for doing so. Kessler, who served as FDA Commissioner from 1990 to 1997, argues this system has created a loophole, permitting the widespread use of ingredients without rigorous, independent government review. His petition, submitted last August, specifically targets corn syrup and numerous other sweeteners and starches, demanding they be removed from the GRAS list. Kennedy’s commitment to “act on Kessler’s petition,” as stated on CBS’ 60 Minutes, isn’t a promise of immediate bans, but a pledge to initiate a re-evaluation process. This is a crucial distinction; the FDA isn’t preemptively labeling these ingredients as dangerous, but rather demanding that manufacturers prove their continued safety under stricter scrutiny.
The implications extend far beyond simple ingredient lists. The Consumer Brands Association, a trade group representing food companies, maintains that its members already “adhere to the FDA’s science and risk-based evaluation of ingredients.” However, the current GRAS process allows for a degree of proprietary science, meaning the data supporting an ingredient’s safety isn’t always publicly accessible or subject to independent verification. Kennedy frames this as a fundamental lack of transparency, stating, “There is no way for any American to know if a product is safe if it is ultraprocessed.” This resonates with growing public distrust in large food corporations and a desire for greater control over dietary choices. It’s worth noting that the Trump administration did release updated dietary guidelines last month, advocating for increased protein and reduced sugar intake, alongside a move away from highly processed foods – a parallel development suggesting a broader governmental focus on food safety and public health.
Original reporting: dallasnews.com.
However, the path forward isn’t without complications. The FDA’s capacity to thoroughly re-evaluate dozens of ingredients is a significant logistical challenge. The agency already faces substantial backlogs in other areas of food safety regulation. Furthermore, the definition of “ultraprocessed” itself is subject to debate. While generally understood to encompass foods high in added sugars, fats, and artificial ingredients, a precise, legally defensible definition will be critical for any regulatory action. The Consumer Brands Association emphasizes the importance of the GRAS process for “enabling companies to innovate to meet consumer demand,” suggesting that overly restrictive regulations could stifle product development and potentially increase food costs.
Limitations to consider include the potential for industry pushback and legal challenges should the FDA move to revoke GRAS status for widely used ingredients. The historical precedent of Kessler’s attempt to regulate tobacco during his tenure as FDA Commissioner – an effort that ultimately failed despite raising public awareness – serves as a cautionary tale. Moreover, attributing obesity and health issues solely to processed carbohydrates is an oversimplification; lifestyle factors, genetics, and socioeconomic conditions all play significant roles.
The next crucial step is observing how the FDA responds to Kessler’s petition and whether Kennedy secures White House approval to close the GRAS loophole. But beyond the immediate regulatory outcome, the more important question is whether this debate will spur a broader conversation about the role of independent scientific review in food safety and the public’s right to know what’s in their food. Will consumers begin to demand greater transparency from food manufacturers, even in the absence of new regulations? The answer to that question will likely shape the future of the food industry for years to come.
